TMCnet News

Drafting and Negotiating Clinical Trial Agreements Programme - London, UK - 8th of November, 2016 - Research and Markets
[February 09, 2016]

Drafting and Negotiating Clinical Trial Agreements Programme - London, UK - 8th of November, 2016 - Research and Markets


Research and Markets (http://www.researchandmarkets.com/research/fxx55p/drafting_and) has announced the addition of the "Drafting and Negotiating Clinical Trial Agreements (London, UK - 8th of November, 2016)" conference to their offering.

Clinical trial agreements are one of the most important agreements in the pharma industry as no research can start without the right agreement in place between sponsor and host organisation. They provide a contract which manages the relationship and responsibilities of both parties, and provide for the allocation of risk, obligations, the protection of academia, terms of collaboration, IP rights and much more.

This intensive one-day programme, delivered by experts in the field, will provide you with a full understanding of the imporance of CTAs. It will describe how the regulatory environment affects them and explain the typical clauses which make up a CTA and what the key differences are between European and the US. By the end of this seminar you will be confident in spotting and addressing issues which arise when negotiating and drafting clinical trial agreements.



This seminar will enable you to:

- Recognise and address the issues that arise when drafting and negotiating international clinical trial agreements (CTAs)


- Gain a better understanding of the legal, contractual and practice issues that affect CTAs concerning investigational medicinal products

- View the issues through the differing perspectives of sponsors, universities, hospitals and individual organisations

- Complete practical exercises on drafting to consolidate learning

- Materials will include examples from pharmaceutical companies CTAs, form the UK National Health Service standard CTD, and from other commonly used CTAs

Supporting documentation

Participants will receive comprehensive supporting documentation that will be a valuable source of reference for the future. These course materials will include examples from pharmaceutical company CTAs, from the UK National Health Service standard CTA, and from other commonly used CTAs.

For more information visit http://www.researchandmarkets.com/research/fxx55p/drafting_and


[ Back To TMCnet.com's Homepage ]